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ABSTRACT 
The US Institute of Medicine reports that one medication error occurs per patient per day in hospital care, and 
other studies indicate that medication administration errors attributed to packaging and/or labeling confusion can 
be as high as 33%. While many engineered products have identifiable features that help establish commonality 
and differentiation within a product family, vital features of consumable products such as medications are often 
not readily apparent in their physical form. As a result, caregivers must rely on the labeling and packaging to 
effectively determine the contents. Adverse Drug Events (ADEs) are the most common category of medical errors 
and include wrong drug, wrong dose, wrong route of administration, and wrong patient. It is estimated that in the 
US each year, medication errors harm at least 1.5 million people, resulting in 106,000 deaths. Computational 
models and associated decision support systems have the potential to improve pharmaceutical delivery safety 
through informed design of packaging features and enhanced situational awareness and decision-making during 
drug identification and administration. Past research has led to the formulation of measures for representing the 
degree of commonality and differentiation of packaging features in pharmaceutical families or versus look-alike 
drugs. Preliminary studies have validated these measures of feature prominence based on feature size and location. 
This paper describes a study using eye tracking to evaluate gaze patterns and further validate these measures. The 
results support the measures and indicate that increased commonality of features results in shorter reaction times, 
but also shorter fixation times. These results have implications in the formulation of a resulting decision support 
system. 
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1. INTRODUCTION 
U.S. Pharmacia estimates that there are approximately 
62.9 million medication dispensing mistakes a year in 
hospitals and pharmacies nationwide (Hicks, 2008), 
with just over three million of these mistakes 
considered to be medically significant. These 
significant mistakes can result from misreading labels, 
misprescribing, giving the wrong dose, or incomplete 
documentation. Classified as ADEs or “Adverse Drug 
Events,” these events are defined and classified as “an 
injury due to medication management rather than the 
underlying condition of the patient” (Aspden, 2007). 
When in a hospital, it is estimated that a patient is on 
the receiving end of these mistakes an average of once 
per day, which can add up to $6,000 to a medical bill 
(Aspden, 2007). These errors can and do have 
detrimental effects to the patients’ health and finances. 
Aside from the individual and familial effects that are 
seen from decreased health and death from illness or 
an ADE, there are large societal costs. These mistakes 
cost the nurses, the pharmacy and the health insurance 
providers. The accrued total of these mistakes must be 
distributed to cover the end cost to the patient as well 
as the healthcare companies. To do this, these costs are 
implemented throughout various industries, costing 
society as a whole not just the ones being directly 
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impacted by the mistakes. Often these mistakes occur 
because of the lack of consistency and regulation 
among package designs. Pharmacists and general 
consumers use cognitive decision-making processes 
to determine the correct medication, so by optimizing 
designs with this in mind, the number of mistakes may 
be able to be reduced greatly.  
Ampuero and Vila performed a study on “Consumer 
Perceptions of Product Packaging” which focused on 
isolating different aspects of the labels on medical 
devices such as color, shape, image and typography 
(Ampuero and Vila, 2006). Isolating individual 
features on a label helped researchers begin to 
manipulate and understand how the brain is perceiving 
and processing the information on the label. Other 
aspects of the packaging of the medication itself can 
lead to a specific perception as to what volume is 
contained within it (Folkes and Matta, 2004). From a 
commercial manufacturer side, it is important to 
understand how the consumer views products on a 
shelf. Young (Young, 2012) presented the “PRS Eye 
Tracking Method” detailing how products on a shelf 
are viewed by customers. Understanding how 
commercial products are viewed and preferred is 
important specifically in package design, since 
consumers are generally novices in regards to looking 
at medication labels. 
2. COMMONALITY/DIFFERENTIATI
ON MEASURES 
A powerful indicator of the importance of visual 
information can be its prominence as measured by size 
and location. To understand how the size and location 
can connote commonality, Shooter, et al. (2008, 2010) 
studied nine packages of Tylenol adult 
acetaminophen. The front panel (the side of the box 
that faces consumers when placed on store shelves) 
was analyzed in terms of its features, the text, and the 
graphics that conveyed information. The front panel 
was treated as a coordinate and normalized to account 
for variations in box size. Figure 1 shows the 
normalized face with each feature element identified 
and its centroid location. The area of each feature on 
the normalized package faces was calculated, 
tabulated, and compared relative to the entire area in 
order to reflect the package face “real estate” occupied 
by each feature as shown in Figure 2.  
Presumably, features deemed by the manufacturer to 
be most important take up the most area on the 
package. The background uses the most space so one 
might expect consideration of color to be important. 
Tylenol uses a consistent shade of red for background 
color across its product family packaging. The brand 
name Tylenol takes up the second largest area, almost 
equal to the background. The type of medication and 
purpose are considerably smaller. Dosage and form 
are smaller still. The variation in normalized size and 
location of the Tylenol brand across the nine packages 
is minimal. 
 
Figure 1:  Front Panel Features’ Positions   
    
 
Figure 2: Relative Area of Front Features 
There is also considerable consistency in location and 
size of the “secondary” information such as 
medication type, purpose, dosage, and form. It is 
evident that the Tylenol product family utilizes a 
package platform of features with an emphasis on 
brand recognition as the most salient common 
element. Information that differentiates among the 
variants of the product is less prominent in the package 
face, but is critical for informed and proper use. It is 
important to note that the Institute for Safe Medication 
Practice has recognized Tylenol as having a high 
number of cases of medication error (Hicks, 2008).  
Cohen and Shooter (2010) followed this study with the 
formulation of measures to represent commonality 
and differentiation of packaging features with regard 
to prominence. In this preliminary investigation, the 
Feature Area Commonality Index (FACI) was 
formulated for packaging. One advantage of the 
commonality indices developed by Thevenot et al. 
(2007) and Alizon, et al. (2009) is that the result ranges 
between 0 and 1. The progression here is intended to 
provide a similar scale. The normalized areas for each 
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feature on each package was determined and 
tabulated. The mean was then calculated for the area 
of that feature across the package family. The 
Proportion Difference from the mean is calculated for 
each instance and represented as shown in Equation 1. 
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     (1)                                                                           
where ?̅?𝐴 is the mean and Aj is the instance value 
The measure can help identify and quantify an outlier 
instance in the packaging family. It is also possible to 
gain perspective on the total family by calculating the 
Average Proportion Difference for each feature using 
the value from each package variant. The intent is to 
describe the degree of commonality for features 
repeated across variants. If a feature is not present on 
a package instance, then that instance is not part of the 
calculation. A value of 1 indicates exact commonality 
across the variants while 0 means they are different. 
The Feature Area Commonality Index (FACI) is then 
calculated as seen in Equation 2 below. 
𝐹𝐹𝐴𝐴𝐹𝐹𝐹𝐹 = 1 − 𝐴𝐴𝐴𝐴𝐴𝐴𝑃𝑃𝐴𝐴𝐴𝐴𝐴𝐴 𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐷𝐷𝑃𝑃𝐷𝐷𝐷𝐷𝐴𝐴𝑃𝑃𝐴𝐴𝑃𝑃𝐷𝐷𝐴𝐴  (2) 
The FACI provides a measure for each feature (i.e., 
Brand Logo) across the package family. The FACI for 
the Brand Logo feature was determined to be 0.92, 
indicating high commonality. The FACI for the Main 
Ingredient was 0.68 and for the Medication Use was 
0.73, which are also strong indicators of commonality. 
It can also be beneficial to represent the aggregate for 
all of the features. The most direct formulation of the 
Aggregate Feature Area Commonality Index (AFACI) 
is to take the average of all of the FACI values for the 
package family. In calculating the AFACI, only the 
feature categories present in the package family are 
included. For example, if the package family does not 
include any instances of the Flavor Text feature 
category, then all instances will have an area of zero, 
which results in a FACI of 1 (all commonly not 
present). If these absent features were included in the 
AFACI, then the result would be skewed toward a 
higher indication of commonality. This formulation 
considers all features as equivalent contributors; 
weighted contributions of different features will be 
investigated as part of this work. The AFACI for all 
features of the Tylenol package family studied was 
calculated to be 0.73, which is a strong indicator of 
commonality. 
A similar approach was taken to formulate the Feature 
Location Commonality Index (FLCI), which is an 
indicator of the commonality and differentiation of the 
location of features across a product family based on 
clustered distances. We then validated both of these 
measures through a cognitive workload analysis study 
with 60 human subjects in Cho et al. (2014). Response 
time and selection accuracy were found to be 
positively correlated with the indices.  
3. PREVIOUS VALIDATION STUDY 
A Penn State University study, Effects of Over-the-
Counter Medication Product Family Design on 
Knowledge Acquisition and Consumer Preferences 
(Cho et al, 2014) sought to study which features in 
Over the Counter (OTC) medical labeling specifically 
can be manipulated to encourage consumers to read 
and process the labels before they choose a medication 
for purchase. To do so, Robitussin and Equate labels 
were altered in Adobe Photoshop to create five 
different variations. These variations included a base 
design without any emphasized features, a design with 
increased font size, a label with inclusion of an accent 
color, a design with an addition of a graphical icon, 
and a variation with all of the emphasized features. 
The study was set up as a survey on Qualtrics software 
(Qualtrics, Provo, UT). Subjects were given 
symptoms and requested to select the corresponding 
medication. Accuracy and selection time were 
measured. 
This study found that “variations in labeling and 
product family design significantly impacts the 
accuracy and efficiency of medication decision 
making and thus has the potential to reduce adverse 
drug events made during the process” (Cho et al, 
2014). The study determined that the overall package 
design did not have a significant impact on the 
accuracy of a subject’s selection. However, increased 
font size exhibited the shortest selection time, 
suggesting that increased font increases efficiency. 
The variation with all of the emphasized features had 
the longest selection time, which suggests that too 
many features could be distracting and decrease 
efficiency in selection. This could point to a limit in 
how many features can be emphasized before it 
detracts a feature’s prominence and creates clutter. In 
looking at design recommendations in other avenues 
of academia, perhaps there is a “design magic number 
seven” that could be used in label design. Such a 
concept would limit how many features can be 
emphasized until they cancel out one another (Miller, 
1956). 
The study at Penn State also found that a higher 
commonality of both AFACI and AFLCI resulted in a 
higher accuracy of selections and a shorter selection 
time. Packages with this higher AFLCI, or higher 
commonality of locations of features across the 
product family, had a lower consumer preference 
rating from participants. The study concluded by 
noting that the task was more of a search task than a 
decision task. It suggested that a future study with an 
eye tracker or employee tasks more closely related to 
the decision making process of selecting medications 
would be appropriate direction to pursue in the future. 
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Additionally, it was suggested that future studies test 
a wider range of OTC labels to create a normal 
distribution for the indices and use product-moment 
correlation. 
This paper investigates and expands upon Cho et al, 
performed in 2014. It examines areas of particular 
interest and importance to individuals interacting and 
giving medications. Within product families, 
commonality of the specific features of interest were 
calculated and then compared against accuracy and 
viewing patterns to further understand how 
information is processed from medical labels.  The 
study validates the efficacy of the commonality and 
differentiation measures for visual features on 
pharmaceutical packaging. Pattern recognition 
techniques and automated calculation of these 
measures will support the rapid exploration of 
alternative designs with the goal of improved 
dispensing of medications. 
4. EXPERIMENTAL PROCEDURE 
Participants 
Fifty-four undergraduates from a small college in 
Pennsylvania were used as the participants of this 
study. Half of the participants were assigned and 
exposed to the Robotussin and the other half to the 
Equate stimuli pool. They were part of a psychology 
class subject pool and received credit for participation.  
Materials and procedure 
Stimuli used in the Cho study (Cho et al., 2014) were 
recreated using Adobe InDesign (Viers et al, n.d.) in 
the same configuration and patterns. The types of 
labels used included base (with no manipulations), 
coloring, icon of person, font size and an image with 
all available manipulations. A total of 50 images were 
created that each consisted of 4 vertical labels placed 
side by side with a corresponding question running 
along the top in the white space. The questions were 
also recreated and matched from the previous study 
(Figure 3). The images were then placed into TOBI 
software (TOBI, Fall Church, VA), 25 Robotussin 
images and 25 Equate images in their own respective 
trial setups. 
The images that were uploaded into the program were 
then processed with areas of interest being identified 
and outlined using the TOBI software (TOBI, Fall 
Church, VA). These Areas of Interest (AOI) were as 
follows: brand name, comparison, name, 
moon/nighttime (specifically used for Robotussin), 
description, active ingredients, non-drowsy, 
symptoms, button, and dots/indicators on the body that 
the drug will apply to. The labels are coded in the 
following manner: 
“ImageID#.AOI#.correct/incorrect”. The labels were 
each individually coded as “correct” or “incorrect” 
relative to the answer to the question to be able to 
separate the data as such. A sample marked up image 
can be seen in Figure 4.  
 
 
Figure 3: Sample stimuli with question of equate, 
used in the study. 
 
 
Figure 4: A sample marked up image of a quartet.  
Upon entering the study, subjects were given the 
“Functional Health Literacy in Adults” survey as well 
as a few general questions about their educational 
background. This was used to measure how much 
effort and attention the subject were giving during the 
study. Afterwards, the TOBI software (TOBI, Fall 
Church, VA) was opened and the eye-tracking tool 
was calibrated to the subject. Once completed, 
subjects were instructed that they were going to be 
shown images and they would have to read the 
questions and click on the “correct” image by 
selecting the circles underneath the corresponding 
label. Once the subjects had seen all 25 images in their 
assigned trial, the study was concluded. A sample 
viewing pattern displayed via heat map can be seen in 
Figure 5.  
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Figure 5: A heat map of one subject’s viewing of an 
image displayed during the study. Yellow indicates 
shorter viewing times, red displays a longer view 
time as indicated in the key in the top left corner of 
the image. 
Images were analyzed using the method utilized by 
(Cho et al, 2014) calculating both location and area 
commonality of each feature on the label and 
comparing them within their product families. With 
this method, product family metrics were used when 
analyzing the correlation between package design and 
selection results. Feature Area Commonality Index 
(FACI) and Feature Location Commonality Index 
(FLCI) were used to describe commonality of an area 
of interest. Feature Area Commonality Index (FACI) 
was determined by calculating the physical area of a 
label of each specific feature covered.  
The FACI was then calculated by subtracting the 
result from equation 1 from 1, mentioned previously 
in equation 2. This is useful as if the commonality is 
consistent across the product family, the FACI is close 
to 1, and if they are completely differentiated, the 
result is 0.    
Feature Location Commonality Index (FLCI) was 
determined in a similar manner to the FACI, but the 
location was determined from the left edge of the 
package to the centroid of the feature. The locations 
were again averaged across product families and then 
subtracted from 1 to calculate the FLCI (Cho et al, 
2014). This specific task allowed for analysis of the 
commonality of location across groups. Each of these 
values, FACI and FLCI, calculated for feature across 
product families were then averaged to create 
aggregates of the FACI and FLCI, further referenced 
as the AFACI and AFLCI. The AFACI and AFLCI 
give a good indication as to the commonality across 
the product family. 
Results 
An item analysis was conducted, rather than analyzing 
by subject, so that the effect of commonality on gaze 
patterns for individual label features (e.g. brand name, 
active ingredients) could be investigated. For each 
image, the following were analyzed: the time to first 
fixation, fixation count, and mean fixation duration for 
each area of interest (AOI; see Method for 
description). AOIs that received no fixations were not 
included in the analysis. The area and location 
commonality indices (FACI & FLCI, respectively) 
reported in Cho et al. (2014) for each AOI (see Table 
1) were also compared.  
A multivariate analysis of variance (MANOVA) was 
conducted on these five variables across the AOI 
regions. Results of the MANOVA reveal a significant 
multivariate effect, Pillai’s Trace=1.28, F (30, 
1050)=12.08, p<.001, 𝜂𝜂𝑝𝑝2=.257, demonstrating a 
difference in the commonality and pattern of eye 
movements for the regions of interest. Univariate 
analyses for this relationship indicate a significant 
effect of AOI on time to first fixation 
(F(6,210)=73.36, p<.001, 𝜂𝜂𝑝𝑝2=.68), mean fixation 
duration (F(6,210)=7.78, p<.001, 𝜂𝜂𝑝𝑝2=.18), fixation 
count (F(6,210)=48.33, p<.001, 𝜂𝜂𝑝𝑝2=.58), FACI 
(F(6,210)=15.47, p<.001, 𝜂𝜂𝑝𝑝2=.31), and FLCI 
(F(6,210)=28.81, p<.001, 𝜂𝜂𝑝𝑝2=.45). 
The primary analysis of interest was the relationship 
between each feature’s commonality (within a product 
family) and eye-gaze patterns; thus, we conducted a 
series of bivariate correlations (6 comparisons, 
Bonferroni corrected α=.008). Both FACI and FLCI 
were significantly negatively correlated with time to 
first fixation (FACI: r(216)= -.418, p<.001; FLCI: 
r(262)= -.535, p<.001; see Figure 1), indicating that 
for AOIs with greater commonality, participants 
fixated on that AOI earlier in the trial. In addition, 
FACI and FLCI were significantly negatively 
correlated with fixation count (FACI: r(216)= -.354, 
p<.001; FLCI: r(262)= -.450, p<.001; see Figure 7) 
and mean fixation duration (FACI: r(216)= -.305, 
p<.001; FLCI: r(262)= -.193, p=.002; see Figure 8). 
This suggests that features with greater commonality 
received fewer fixations and those fixations were 
shorter in duration. 
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Table 1. Means and standard deviations of the eye-tracking metrics and commonality indices for the 7 
prominent AOIs.  
 
 
Time to First 
Fixation (ms) Fixation Count 
Fixation 
Duration (s) AFACI AFLCI 
Feature/AOI M SD M SD M SD M SD M SD 
Brand Name 29.52 23.64 1.65 1.64 0.31 0.34 0.9793 0.01 0.9907 0.01 
Name 94.59 24.98 7.40 3.47 1.13 0.39 0.7067 0.11 0.9391 0.01 
Description 102.70 35.66 6.79 2.32 1.00 0.26 0.7987 0.19 0.8856 0.00 
Active 
Ingredients 
70.47 37.36 2.87 1.62 0.55 0.41 0.6938 0.26 0.9415 0.04 
Non-Drowsy  71.52 19.50 2.28 0.79 0.39 0.15 0.9061 0.12 0.9229 0.01 
Symptoms 144.42 32.52 14.73 4.93 1.33 0.45 0.6232 0.32 0.9027 0.06 
Dots 16.81 9.88 0.43 0.24 0.10 0.05 0.9686 0.02 0.9681 0.02 
Note: Table 1 only displays AOIs that had commonality indices reported in Cho et al. (2014).  
 
 
Figure 6. Scatterplot showing relationship between commonality (FACI and FLCI) and time to first fixation 
(ms).  
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Figure 7. Scatterplot showing relationship between commonality (FACI and FLCI) and mean fixation count 
across areas of interest (AOIs). 
 
 
Figure 8. Scatterplot showing relationship between commonality (FACI, FLCI) and mean fixation duration 
across areas of interest. 
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5. DISCUSSION AND IMPLICATIONS 
Examining the results, it is supported that as subjects 
become more familiar with the location of certain 
pieces of information, or specific features on the 
labels, less time is spent looking at these features. 
The significance of the correlations we found 
between the FLCI and FACI reflect this hypothesis. 
From this data, it is suggested that increasing 
commonality values among product families, in both 
location and area, will help to decrease reaction time. 
An increase in commonality could be applied to both 
over the counter medication as well as 
pharmaceuticals.  
A shorter reaction time could be helpful and harmful. 
Decreased reaction time may allow for the 
pharmacist or consumer to attain more information 
from the label in a shorter amount of time, or it could 
decrease the saliency of the information as less time 
is being spent reading the label. More information in 
less time would ideally mean fewer mistakes would 
be made, as the majority of the information on the 
label would cross through the handler’s field of 
vision. However, more information could also mean 
an overload of information in the field of vision so 
less of it is retained. Commonality and regulation 
among product families affect nurses administering 
drugs in the hospital setting. For example, if the 
same information (such as dosage) was in a 
particular location on every vial the nurse would 
have to exert minimal effort to determine what the 
dosage was any given vial, but perhaps they would 
then minimally view the numerical information 
given by the feature.  
With the knowledge that commonality helps to 
increase reaction times, future studies will to take 
this data and build on this concept. A similar study 
will be performed using prescription labels and 
medical staff. Since the previous subject pool uses 
novice medical label viewers, this study would 
ideally help to support the idea that commonality 
influence novices as well as experts with years of 
training. This subject pool is exposed to medical 
packaging every day, and would be most likely to 
notice or be affected by changes in labels. 
Moving forward new labels will be created, with 
information that has been manipulated to contain 
high or low levels of commonalities. The different 
information found in these areas will test specifically 
if high levels of commonalities decrease salience of 
information. It is important to see how the location 
of information influences the accuracy and 
consistency of information retrieval as opposed to 
just reaction time. Results of the current study 
support that there is less time spent in areas with high 
commonality, but the researchers are currently 
unable to determine how salient the information is in 
those high commonality locations. If commonality 
decreases reaction time, than perhaps the 
information provided in these high commonality 
areas are not as salient as originally intended.  
To improve validity of results, comparing two-
dimensional renderings of labels and a more realistic 
rendering is of interest to determine which format 
will provide a more accurate replica of what nurses 
would experience in the field handling medical vials. 
Future studies will investigate the brightness of a 
computer screen versus brightness of physical labels 
and how the lighting of testing scenarios might affect 
the ability for results to extend to a physical 
pharmacy or hospital dispensary. Studies could also 
delve into color theory and examine how lumosity 
might influence choices of medical labels. With a 
commonality in lumosity or actual color within the 
feature, perhaps saliency would be able to increase 
with commonality.  
6. IMPLICATIONS FOR DECISION 
SUPPORT SYSTEM 
The study has validated the saliency of the measures 
for commonality and differentiation of packaging 
features with improved medication selection. There 
are tens of thousands of medications on the market 
both over-the-counter and prescription. The intent is 
to create a database of diverse pharmaceutical 
packages that will include the Packaging 
Commonality Differentiation Indices and highlights 
of identified “trouble spots”. This information will 
be used to improve upon the current pharmacy 
dispensary approach where red labels are used as 
warnings for potential identification hazards, as well 
as to improve on the internal labeling used for in-
patients. The computational models for creating the 
indices in the database need to be automated as much 
as possible to relieve burden on entry of new 
package information. For example, the information 
capture has been simplified, and the computation of 
the FACI and FLCI indices has been automated by 
using software that automatically measures the area 
and centroid locations of features; and then 
calculates the indices. However, it is desired to 
automate the recognition and categorization of 
features supplied to the measures. Techniques of 
pattern recognition and cluster analysis will 
dramatically improve this process. The intent is to 
develop a system that will provide information to a 
package designer that will enable the rapid 
exploration of alterative designs with improved 
medication administration outcomes. 
7. CONCLUSIONS 
This paper has introduced a computational model for 
representing the commonality and differentiation of 
visual features on pharmaceutical packages. The 
measures had been previously validated through a 
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workflow analysis study. This study used eye 
tracking to evaluate gaze patterns for novice 
subjects. The results support the measures and 
indicate that increased commonality of features 
results in shorter reaction times, but also shorter 
fixation times. A similar study is currently being 
conducted with healthcare professionals including 
nurses and pharmacists to explore the correlations in 
healthcare settings. The intent is to develop a 
working decision support system that will support 
the exploration of alternatives to packaging 
designers. The implications for decision support in 
organization is also being examined as well as the 
structure of pharmaceutical dispensing. The 
researchers have taken the approach of validating the 
measures before the development of the decision 
support system to ensure the efficacy of the 
approach. The calculation and representation of the 
measures have been automated. The team is 
currently exploring techniques for pattern 
recognition to automate the recognition and 
categorization of salient features. 
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